Castlecreekbio.com

Castlecreekbio.com has Server used 104.154.239.211 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2020-01-07 (1 year, 198 days) and hosted in Mountain View United States, server ping response time 32 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Castlecreekbio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Castlecreekbio.com
2 Castle creek biotech
3 Castle creek biopharma
4 Castle creek bioscience
5 Castle creek biosciences llc
6 Castle creek biosciences careers
7 Castle creek boat ramp
8 Castle creek binghamton
9 Castle creek boat ramp lake pleasant az

Hosting Provider

Website: Castlecreekbio.com
Hostname: 211.239.154.104.bc.googleusercontent.com
Country:
Region: CA
City: Mountain View
Postal Code: 94043
Latitude: 37.419200897217
Longitude: -122.05740356445
Area Code: 650
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Abvmfeasterville.org (3 seconds ago)

   » Ciclo21.com (3 seconds ago)

   » Arlmarshalltown.com (3 seconds ago)

   » Wurthlac.com (4 seconds ago)

   » Optimizeforoutcomes.com (12 seconds ago)

   » Masterbond.com (1 seconds ago)

   » Tourisme-charlevoix.com (0 seconds ago)

   » Calstarrods.net (5 seconds ago)

   » Optimoroute.com (14 seconds ago)

   » Castlecreekbio.com (0 seconds ago)

Results For Websites Listing

Found 42 Websites with content related to this domain, It is result after search with search engine

Castle Creek Biosciences: Cell And Gene Therapy Company

Castlecreekbio.com   DA: 18 PA: 18 MOZ Rank: 36

  • Castle Creek Biosciences Announces First Patient Dosed in DeFi-RDEB Phase 3 Clinical Trial of D-Fi Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
  • Company manufacturing and distributing D-Fi at in-house, cGMP commercial-scale facility in greater Philadelphia area

Castle Creek Biosciences, Inc. LinkedIn

Linkedin.com   DA: 16 PA: 23 MOZ Rank: 40

  • As a veteran cell & #genetherapy professional, Kevin Smith’s experience and guidance as Manager of Production and Logistics

Castle Creek Biosciences

Facebook.com   DA: 16 PA: 15 MOZ Rank: 33

  • Castle Creek Biosciences, Exton, Pennsylvania
  • 74 likes · 5 talking about this · 1 was here
  • Dedicated to making life better for people suffering from rare diseases with few or no treatment options.

Castle Creek Biosciences Company Profile: Valuation

Pitchbook.com   DA: 13 PA: 27 MOZ Rank: 43

  • Castle Creek Biosciences General Information Description
  • Developer of a fibroblast technology platform designed to create transformative cell and gene therapies
  • The company's platform focus on extracting fibroblast cells from a patient's own skin, create localized cell and gene therapies that are compatible with the unique biology of each patient, and have the potential to address the

Castle Creek Biosciences

Facebook.com   DA: 16 PA: 42 MOZ Rank: 62

  • We know clinical trials can be overwhelming for many families who are considering participation
  • Recently, we created an educational resource to help patients and families understand more about the #clinicaltrial process
  • We hope these frequently asked questions and answers are valuable for

Castle Creek Bio Company Profile

Bizjournals.com   DA: 19 PA: 50 MOZ Rank: 74

  • 405 Eagleview Boulevard, Exton, PA 19341
  • [1] Revenue last updated on Jan 29, 2018 …

Castle Creek Biosciences Announces $75 Million Investment

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 77

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • About Paragon Biosciences Paragon is a life …

Castle Biosciences: Molecular Diagnostics For Cancers

Castlebiosciences.com   DA: 21 PA: 21 MOZ Rank: 49

Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.

Pipeline Of Portfolio Companies – Paragon Biosciences

Paragonbiosci.com   DA: 17 PA: 11 MOZ Rank: 36

  • Concentrating on cell therapy treatments for serious diseases with high unmet needs, with an initial focus on the eye
  • Creating treatments for central nervous system movement disorders and fluency disorders, including Tourette syndrome and childhood-onset fluency disorder (stuttering) in adults

Castle Creek Biosciences (CCBS) Company Profile & Overview

Stockanalysis.com   DA: 17 PA: 21 MOZ Rank: 47

  • Castle Creek Biosciences is a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options
  • Our proprietary platform serves as the foundation for developing personalized, targeted and redosable

Castle Creek Biosciences Company Profile

Craft.co   DA: 8 PA: 25 MOZ Rank: 43

  • Castle Creek Biosciences has 38 employees at their 1 location and $174.8 m in total funding,
  • See insights on Castle Creek Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Cell And Gene Therapy Innovator Castle Creek Biosciences

Dailyamerican.com   DA: 21 PA: 50 MOZ Rank: 82

  • For more information, visit castlecreekbio.comor follow Castle Creek on Twitter @CastleCreekBio
  • Paragon Biosciences is a life science innovator that creates, invests in

Castle Creek Biosciences

Crunchbase.com   DA: 18 PA: 38 MOZ Rank: 68

  • Contact Email [email protected]
  • Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need
  • It was founded in 2015 and headquartered in Pennsylvania, United States.

IPO: Castle Creek Biosciences

Renaissancecapital.com   DA: 26 PA: 46 MOZ Rank: 85

  • Website www.castlecreekbio.com: IPO Pro - "The Ultimate Resource for IPOs" Don't risk buying another IPO without IPO Pro
  • IPO Pro - "The Ultimate Resource for IPOs" Don't risk buying another IPO without IPO Pro

Castle Creek Biosciences Announces First Patient Dosed In

Biospace.com   DA: 16 PA: 50 MOZ Rank: 80

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • Paragon is a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals
  • The company's current portfolio

Cell And Gene Therapy Innovator Castle Creek Biosciences

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 77

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • About Paragon Biosciences Paragon Biosciences is a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and gene therapy and synthetic biology utilizing artificial intelligence.

Castle Creek Biosciences Announces First Patient Dosed In

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 84

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio

Castle Creek Biosciences Announces First Patient Dosed In

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 85

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio

Executive Assistant Job In Exton, PA At CastleCreek

Ziprecruiter.com   DA: 20 PA: 50 MOZ Rank: 88

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • CastleCreek Biosciences Castle Creek is a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment

Castle Creek Biosciences Scoops Up $75M

Vcnewsdaily.com   DA: 15 PA: 50 MOZ Rank: 84

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • About Paragon Biosciences Paragon is a life science innovator that invests in, builds, and advises bioscience companies
  • Our mission is to serve patients living with severe medical conditions which do not yet have adequate treatments

Castle Creek Biosciences Desktop Support Administrator In

Snagajob.com   DA: 16 PA: 15 MOZ Rank: 51

  • In addition, Castle Creek is developing FCX-013, a gene therapy for the treatment of moderate to severe localized scleroderma
  • Castle Creek is a portfolio company of Paragon Biosciences
  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio.

Castle Creek VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 91

"Castle Creek Biosciences, Inc., a privately-held, clinical-stage cell and gene therapy company, is focused on developing and commercializing innovative therapies for patients living with serious disorders with unmet medical needs.

Press Kit – Castle Creek

Castlecreekband.com   DA: 23 PA: 10 MOZ Rank: 55

  • Castle Creek Bio Castle Creek is comprised of front woman Kim Monroe and a changing cast of musicians as small as an acoustic duo or as large as a six piece band
  • With one EP and one full length disk each garnering critical acclaim, and three SAMMY awards under her belt Kim Monroe has consistently impressed audiences with her unique songwriting

Castle Creek Biosciences Announces First Patient Dosed In

Pipelinereview.com   DA: 18 PA: 50 MOZ Rank: 91

  • For more information, visit castlecreekbio.com or follow Castle Creek on Twitter @CastleCreekBio
  • Paragon is a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals
  • The company's current portfolio

Castle Creek Pharmaceuticals LLC

Bloomberg.com   DA: 17 PA: 28 MOZ Rank: 69

  • Castle Creek Pharmaceuticals LLC operates as a pharmaceutical company
  • The Company develops and commercializes specialty drugs for the treatment of patients with medical needs.

Your Cells And Our Science: Investigating A Personalized

Defi-rdeb.com   DA: 17 PA: 30 MOZ Rank: 72

  • Your Cells and Our Science: Investigating a Personalized Therapeutic Approach to RDEB
  • The DeFi-RDEB Phase 3 study is evaluating the safety and efficacy of FCX-007 (also known as D-Fi), an investigational gene therapy for the localized treatment of wounds that can lead to serious health complications in recessive

Dedicated To Making Life Better For People With Rare And

Fibrocell.com   DA: 13 PA: 50 MOZ Rank: 89

  • castlecreekbio.com “We believe our experience, expertise and proven processes provide us with the capability to deliver potentially transformative, localized therapies to these patients
  • We can make a difference.” — Dr
  • Mary Spellman, Chief Medical Officer Corporate Contact Karen Casey Castle Creek Biosciences, Inc.

Working At Castle Biosciences Glassdoor

Glassdoor.com   DA: 17 PA: 50 MOZ Rank: 94

  • Glassdoor gives you an inside look at what it's like to work at Castle Biosciences, including salaries, reviews, office photos, and more
  • This is the Castle Biosciences company profile.

Castle Creek Biosciences Inc.

Biocentury.com   DA: 18 PA: 39 MOZ Rank: 85

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more.

Castle Creek Biosciences Treats First Patient In Phase 1/2

Drug-dev.com   DA: 12 PA: 50 MOZ Rank: 91

  • For more information, visit castlecreekbio.com
  • Paragon is a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals
  • The company’s current portfolio includes Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony

Fibrocell Science, Inc. Company Information Drugs.com

Drugs.com   DA: 13 PA: 44 MOZ Rank: 87

  • Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products
  • This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment
  • Data sources include IBM Watson Micromedex (updated 1 July 2021), Cerner Multum™ (updated 1 July 2021), …

Castle Creek Biosciences

Ne-np.facebook.com   DA: 18 PA: 16 MOZ Rank: 65

  • Castle Creek Biosciences, Exton, Pennsylvania
  • ७९ जनाले मन पराउनुभयो · ४ जनाले यसको बारेमा कुरागर्दै छन् · 1 was here
  • Dedicated to making life better for people suffering from rare diseases with few

CELL & GENE THERAPY AND CONNECTED HEALTH >35 Cell & …

Ceocouncilforgrowth.com   DA: 23 PA: 50 MOZ Rank: 18

  • castlecreekbio.com Exton, PA Century Therapeutics centurytx.com Philadelphia, PA Est
  • 2018 Cerecor flowcytometryservices
  • 2015 Certainty Therapeutics Wistar Institute Spinout Est
  • 2020 Code Therapeutics codebiotx.com Therapeutics Hatfield, PA Est
  • 2021 EpiGenOnco gyroscopetx.com epigenonco.com Philadelphia, PA Est

Rajesh B. Shukla, PhD

Linkedin.com   DA: 16 PA: 17 MOZ Rank: 66

  • Objective: Design, plan, implement and execute adaptive design confirmatory (Phase 2,3) global clinical trials for the

Jeff Aronin Announces Matthew Gantz As CEO Of Castle Creek

Techbullion.com   DA: 15 PA: 50 MOZ Rank: 99

  • Castle Creek Biosciences recently announced the appointment of Matthew Gantz as the organization’s President and Chief Executive Officer
  • The appointment will also include a position on the board of directors for the privately held clinical-stage cell and gene therapy company
  • Castle Creek Biosciences focuses on developing and commercializing disease-modifying autologous fibroblast …

Castle Creek Pharmaceutical Holdings To Acquire Fibrocell

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 15

Castle Creek Pharmaceutical Holdings will acquire Fibrocell for a total consideration of approximately $63.3 million, including repayment of debt and other financial instruments, in cash

Castle Creek Biosciences’s Competitors, Revenue, Number Of

Owler.com   DA: 13 PA: 23 MOZ Rank: 72

  • Castle Creek Biosciences's top competitors include AavantiBio, Caribou Biosciences and Sana Biotechnology
  • See the full list of Castle Creek Biosciences competitors, plus revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform.

Castle Creek Biosciences Announces $75 Million Investment

Leagold.ceo.ca   DA: 14 PA: 50 MOZ Rank: 13

  • The information on this Website is not reliable and not intended to provide tax, legal, or investment advice
  • Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.

Recently Analyzed Sites

Abvmfeasterville.org (4 seconds ago)

Ciclo21.com (4 seconds ago)

Arlmarshalltown.com (4 seconds ago)

Wurthlac.com (5 seconds ago)

Optimizeforoutcomes.com (13 seconds ago)

Masterbond.com (2 seconds ago)

Tourisme-charlevoix.com (1 seconds ago)

Calstarrods.net (6 seconds ago)

Optimoroute.com (15 seconds ago)

Castlecreekbio.com (1 seconds ago)

Petersco.net (13 seconds ago)

Unicellinc.com (20 seconds ago)

Acprail.com (5 seconds ago)

Pcbaevents.com (2 seconds ago)

Skialot.com (0 seconds ago)

Chicagodermatology.com (7 seconds ago)

Ncmotorcoach.org (2 seconds ago)

Qlalabservices.com (9 seconds ago)